UVC PureLight 360​ Proven To Kill The Spread Of COVID-19 Coronavirus

UVC PureLight 360​, a new UVC induction light disinfection and sanitization technology, has passed testing that shows the technology kills the indoor spread of numerous pathogens, including COVID-19 Coronavirus.

UVC PureLight 360 Test results from a leading independent international laboratory confirm that the patent-pending 320W UVC Induction/LED prototype from Miami-based UVC PureLight 360 LLC inactivates more than 99.9% of COVID-19 in a 16′ X 16′ room in as little as 3.5 minutes.

COVID-19 has caused more than 1.2 million deaths worldwide in 2020, and the resurgence of the virus in the U.S. has led to more than 10 million current infections.

“UVC light is a proven method to sanitize indoor spaces from many known pathogens, and it’s a critical health advancement to know that our new technology kills the spread of this deadly virus,” said Dr. Minghsun Liu, microbiologist, infectious disease specialist, and UVC PureLight 360TM advisory board member.

The technology also kills germs and bacteria that cause common colds and flu, SARS, MERS, H1N1 and other health threats.

UVC PureLight 360​TM was developed to create safe, clean indoor spaces in a wide variety of locations such as medical facilities, hotels, offices, schools, retail, fitness centers, restaurants and more.

“When launching UVC PureLight 360, we wanted to ensure our device was an effective, tested and proven solution for all these settings,” said Alan Mandel, CEO and co-founder of UVC PureLight 360 LLC. “These verified test results prove our mission to help guests, patients and staff have peace of mind. This is a big step in overcoming the pandemic, as well as the economic hardship it has caused.”

In addition to quickly killing virulent pathogens, the UVC light leaves behind no odors or damaging residues. Currently, most businesses and facilities must spray or wipe down surfaces with harsh chemicals and other antibacterial products to remediate COVID-19.

UVC PureLight 360​TM features a hybrid UVC and LED bulb tower atop a maneuverable cart for easy room-to-room transport. The 320W output is precisely calculated to be effective against a wide range of bacteria and viruses.

The production version of the device is expected to launch in January when health officials fear COVID-19 infections will be surging. While the device is in final development, the company is aligning with distributors across the globe.

“COVID-19 has been an unprecedented public health and economic crisis,” Mandel said. “We’re proud to deliver this solution to businesses, institutions, and the public.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy